Van Hoose Kyri K. 4
4 · Dermata Therapeutics, Inc. · Filed Jan 5, 2022
Insider Transaction Report
Form 4
Van Hoose Kyri K.
SVP, CFO
Transactions
- Award
Stock Option (right to buy)
2022-01-03+30,000→ 30,000 totalExercise: $1.88Exp: 2032-01-02→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option will vest as to 40% upon the 12 month anniversary of the grant date, and will vest as to 60% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.